Nikola A. Bowden
Papers
1
Total Citations
13
H-Index
1
About
Dr. Nikola A. Bowden is a leading translational researcher whose work focuses on the molecular underpinnings and therapeutic vulnerabilities of rare and treatment-resistant gynecologic cancers, particularly low-grade serous ovarian carcinoma (LGSOC). Her major contributions include pioneering high-throughput drug screening approaches that directly address the critical lack of effective therapies for LGSOC, a disease molecularly distinct from more common ovarian cancers. Her landmark 2024 study, which has already garnered 13 citations, identified novel therapeutics by systematically testing hundreds of compounds against LGSOC models, offering new hope for patients with limited options. Beyond this, Dr. Bowden’s research integrates genomic profiling with functional drug testing to uncover actionable targets, bridging the gap between laboratory discovery and clinical application. Her work has been instrumental in highlighting the unique biology of LGSOC, challenging the one-size-fits-all treatment paradigm inherited from high-grade serous carcinoma trials. With a growing citation impact and a reputation for tackling challenging tumor types, Dr. Bowden is shaping the future of precision oncology for rare ovarian cancers, providing a roadmap for developing tailored therapies where clinical trials have historically fallen short.
Research Focus
Key Achievements
Top Papers
- 1